Epidermal Growth Factor Receptor-mediated Tissue Transglutaminase Overexpression Couples Acquired Tumor Necrosis Factor-related Apoptosis-inducing Ligand Resistance and Migration through c-FLIP and MMP-9 Proteins in Lung Cancer Cells
出版年份 2011 全文链接
标题
Epidermal Growth Factor Receptor-mediated Tissue Transglutaminase Overexpression Couples Acquired Tumor Necrosis Factor-related Apoptosis-inducing Ligand Resistance and Migration through c-FLIP and MMP-9 Proteins in Lung Cancer Cells
作者
关键词
-
出版物
JOURNAL OF BIOLOGICAL CHEMISTRY
Volume 286, Issue 24, Pages 21164-21172
出版商
American Society for Biochemistry & Molecular Biology (ASBMB)
发表日期
2011-04-28
DOI
10.1074/jbc.m110.207571
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Treatment of metastatic breast cancer: second line and beyond
- (2010) H. Roche et al. ANNALS OF ONCOLOGY
- Transglutaminase 2: A multi-tasking protein in the complex circuitry of inflammation and cancer
- (2010) Kapil Mehta et al. BIOCHEMICAL PHARMACOLOGY
- Immunity, Inflammation, and Cancer
- (2010) Sergei I. Grivennikov et al. CELL
- TRAIL receptor signaling and therapeutics
- (2010) Junaid Abdulghani et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Inhibition of tissue transglutaminase sensitizes TRAIL-resistant lung cancer cells through upregulation of death receptor 5
- (2010) Manuela Frese-Schaper et al. FEBS LETTERS
- A smac mimetic reduces TNF Related Apoptosis Inducing Ligand (TRAIL)-induced invasion and metastasis of cholangiocarcinoma cells
- (2010) Christian D. Fingas et al. HEPATOLOGY
- Molecular basis for therapy resistance
- (2010) Per E. Lønning Molecular Oncology
- EGF potentiated oncogenesis requires a tissue transglutaminase-dependent signaling pathway leading to Src activation
- (2010) B. Li et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- TGM2 Is a Novel Marker for Prognosis and Therapeutic Target in Colorectal Cancer
- (2009) Norikatsu Miyoshi et al. ANNALS OF SURGICAL ONCOLOGY
- Transglutaminase 2 expression levels regulate sensitivity to cystamine plus TRAIL-mediated apoptosis
- (2009) Ji Hoon Jang et al. CANCER LETTERS
- Anti-Apoptotic Mechanisms of Drug Resistance in Cancer
- (2009) T. Wilson et al. CURRENT CANCER DRUG TARGETS
- TRAIL receptor targeting therapies for non-small cell lung cancer: Current status and perspectives
- (2009) J.H. Stegehuis et al. DRUG RESISTANCE UPDATES
- EGFR-directed therapies to treat non-small-cell lung cancer
- (2009) Cheryl Ho et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Tissue Transglutaminase Is an Essential Participant in the Epidermal Growth Factor-stimulated Signaling Pathway Leading to Cancer Cell Migration and Invasion
- (2009) Marc A. Antonyak et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Tissue Transglutaminase Regulates Matrix Metalloproteinase-2 in Ovarian Cancer by Modulating cAMP-response Element-binding Protein Activity
- (2009) Minati Satpathy et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Transglutaminase 2 as a cisplatin resistance marker in non-small cell lung cancer
- (2009) Kang-Seo Park et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Mapatumumab, an Antibody Targeting TRAIL-R1, in Combination With Paclitaxel and Carboplatin in Patients With Advanced Solid Malignancies: Results of a Phase I and Pharmacokinetic Study
- (2009) Stephen Leong et al. JOURNAL OF CLINICAL ONCOLOGY
- Apoptosis and cancer: mutations within caspase genes
- (2009) S Ghavami et al. JOURNAL OF MEDICAL GENETICS
- Acquired Activation of the Akt/Cyclooxygenase-2/Mcl-1 Pathway Renders Lung Cancer Cells Resistant to Apoptosis
- (2009) W. Chen et al. MOLECULAR PHARMACOLOGY
- Luteolin, a Flavonoid with Potential for Cancer Prevention and Therapy
- (2008) Yong Lin et al. CURRENT CANCER DRUG TARGETS
- Tumor resistance to apoptosis
- (2008) Simone Fulda INTERNATIONAL JOURNAL OF CANCER
- Akt-mediated eminent expression of c-FLIP and Mcl-1 confers acquired resistance to TRAIL-induced cytotoxicity to lung cancer cells
- (2008) X. Wang et al. MOLECULAR CANCER THERAPEUTICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now